Evaluation of the effect of intracavernous stem cell injection on the treatment of erectile dysfunction in diabetic patients
Phase 3
- Conditions
- Erectile dysfunction.Male erectile dysfunction
- Registration Number
- IRCT20190517043609N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Erectal dysfunction
Diabetes
Ages: 55-75 years
Exclusion Criteria
Hypertension
Hyperlipidemia
Obesity
Low testosterone
High prolactin
Hypothyroidism
Hyperthyroidism
Impaired Luteinizing Hormone ( LH)
Impaired Follicle Stimulating Hormone ( FSH)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Erectile function. Timepoint: 3 and 6 months after the injection. Method of measurement: Questionnaire IIEF5 (International Index of Erectile Dysfunction Inventory) and Patient Statement and Color Doppler Sonography.
- Secondary Outcome Measures
Name Time Method . Timepoint: . Method of measurement: .